Clinical, experimental, and genomic differences between intermediately pathogenic, highly pathogenic, and epidemic Streptococcus suis

Journal of Infectious Diseases

Volumn 199, Issue 1, 2009, Pages 97-107

  Ye, Changyun ^a,b   Zheng, Han ^a,b   Zhang, Ji ^b   Jing, Huaiqi ^b   Wang, Lei ^c   Xiong, Yanwen ^a   Wang, Wei ^c   Zhou, Zhemin ^c   Sun, Qiangzheng ^a   Luo, Xia ^a   Du, Huamao ^a   Gottschalk, Marcelo ^d   Xu, Jianguo ^a,b,e  

^a State Key Laboratory for Infectious Disease Prevention and Control   (China)

^b National Institute for Communicable Disease Control and Prevention   (China)

^c NANKAI UNIVERSITY   (China)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e NONE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENOME; BACTERIAL MENINGITIS; BACTERIAL STRAIN; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; GENOMIC ISLAND; HUMAN; MOLECULAR EVOLUTION; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS SUIS; TOXIC SHOCK SYNDROME; VIRULENCE;

CHINA; DISEASE OUTBREAKS; GENOME, BACTERIAL; HUMANS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS SUIS; SURVIVAL ANALYSIS; SURVIVORS; VIRULENCE;

EID: 58749114200     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/594370     Document Type: Article

References (41)

1. Gottschalk M, Segura M, Xu J. Streptococcus suis infections in humans: the Chinese experience and the situation in North America. Anim Health Res Rev 2007; 8:29-45.
2. Gottschalk M, Lebrun A, Wisselink H, Dubreuil JD, Smith H, Vecht U. Production of virulence-related proteins by Canadian strains of Streptococcus suis capsular type 2. Can J Vet Res 1998; 62:75-9.
3. Yu H, Jing H, Chen Z, et al. Human Streptococcus suis outbreak, Sichuan, China. Emerg Infect Dis 2006; 12:914-20.
4. Charland N, Nizet V, Rubens CE, Kim KS, Lacouture S, Gottschalk M. Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells. Infect Immun 2000; 68:637-43.
5. Reams RY, Glickman LT, Harrington DD, Thacker HL, Bowersock TL. Streptococcus suis infection in swine: a retrospective study of 256 cases. Part II. Clinical signs, gross and microscopic lesions, and coexisting microorganisms. J Vet Diagn Invest 1994; 6:326-34.
6. Normile D. Infectious diseases. WHO probes deadliness of China's pig-borne disease. Science 2005; 309:1308-9.
7. King SJ, Leigh JA, Heath PJ, et al. Development of a multilocus sequence typing scheme for the pig pathogen Streptococcus suis: identification of virulent clones and potential capsular serotype exchange. J Clin Microbiol 2002; 40:3671-80.
8. Ye C, Zhu X, Jing H, et al. Streptococcus suis sequence type 7 outbreak, Sichuan, China. Emerg Infect Dis 2006; 12:1203-8.
9. Tarradas C, Arenas A, Maldonado A, Luque I, Miranda A, Perea A. Identification of Streptococcus suis isolated from swine: proposal for biochemical parameters. J Clin Microbiol 1994; 32:578-80.
10. Wisselink HJ, Smith HE, Stockhofe-Zurwieden N, Peperkamp K, Vecht U. Distribution of capsular types and production of muramidase-released protein (MRP) and extracellular factor (EF) of Streptococcus suis strains isolated from diseased pigs in seven European countries. Vet Microbiol 2000;74:237-48.
11. Marois C, Bougeard S, Gottschalk M, Kobisch M. Multiplex PCR assay for detection of Streptococcus suis species and serotypes 2 and 1/2 in tonsils of live and dead pigs. J Clin Microbiol 2004; 42:3169-75.
12. Staats JJ, Plattner BL, Stewart GC, Changappa MM. Presence of the Streptococcus suis suilysin gene and expression of MRP and EF correlates with high virulence in Streptococcus suis type 2 isolates. Vet Microbiol 1999; 70:201-11.
13. Khan SS, Smith MS, Reda D, Suffredini AF, McCoy JP, Jr. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B Clin Cytom 2004; 61:35-9.
14. Berthelot-Herault F, Gottschalk M, Morvan H, Kobisch M. Dilemma of virulence of Streptococcus suis: Canadian isolate 89-1591 characterized as a virulent strain using a standardized experimental model in pigs. Can J Vet Res 2005; 69:236-40.
15. Higgins R, Gottschalk M, Beaudoin M, Rawluk SA. Distribution of Streptococcus suis capsular types in Quebec and western Canada. Can Vet J 1992; 33:27-30.
16. Chen C, Tang J, Dong W, et al. A glimpse of streptococcal toxic shock syndrome from comparative genomics of S. suis 2 Chinese isolates. PLoS ONE 2007; 2:e315.
17. Ewing B, Green P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res 1998; 8:186-94.
18. Perna NT, Plunkett G III, Burland V, et al. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 2001; 409:529-33.
19. Langford P, Williams AE, Kroll JS. Superoxide dismutases of pathogenic and non-pathogenic Streptococcus suis type 2 isolates. FEMS Microbiol Lett 1991; 61:347-50.
20. Jobin MC, Martinez G, Motard J, Gottschalk M, Grenier D. Cloning, purification, and enzymatic properties of dipeptidyl peptidase IV from the swine pathogen Streptococcus suis. J Bacteriol 2005; 187:795-9.
21. Upton M, Tagg JR, Wescombe P, Jenkinson HF. Intra-and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides. J Bacteriol 2001; 183:3931-8.
22. Engelke G, Gutowski-Eckel Z, Kiesau P, Siegers K, Hammelmann M, Entian KD. Regulation of nisin biosynthesis and immunity in Lactococcus lactis 6F3. Appl Environ Microbiol 1994; 60:814-25.
23. Tang J, Wang C, Feng Y, et al. Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. PLoS Med 2006; 3:e151.
24. Stevens DL. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis 1995; 1:69-78.
25. Korman TM, Boers A, Gooding TM, Curtis N, Visvanathan K. Fatal case of toxic shock-like syndrome due to group C streptococcus associated with superantigen exotoxin. J Clin Microbiol 2004; 42:2866-9.
26. Dominguez-Punaro MC, Segura M, Plante MM, Lacouture S, Rivest S, Gottschalk M. Streptococcus suis serotype 2, an important swine and human pathogen, induces strong systemic and cerebral inflammatory responses in a mouse model of infection. J Immunol 2007; 179:1842-54.
27. Norrby-Teglund A, Pauksens K, Norgren M, Holm SE. Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections. Scand J Infect Dis 1995; 27:125-30.
28. Cusumano V, Mancuso G, Genovese F, et al. Role of gamma interferon in a neonatal mouse model of group B streptococcal disease. Infect Immun 1996; 64:2941-4.
29. Heinzel FP. The role of IFN-gamma in the pathology of experimental endotoxemia. J Immunol 1990; 145:2920-4.
30. Goldmann O, Chhatwal GS, Medina E. Contribution of natural killer cells to the pathogenesis of septic shock induced by Streptococcus pyogenes in mice. J Infect Dis 2005; 191:1280-6.
31. Faulkner L, Cooper A, Fantino C, Altmann DM, Sriskandan S. The mechanism of superantigen-mediated toxic shock: not a simple Th1 cytokine storm. J Immunol 2005; 175:6870-7.
32. Pruitt JH, Copeland EM III, Moldawer LL. Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock. Shock 1995; 3:235-51.
33. Mancuso G, Cusumano V, Genovese F, Gambuzza M, Beninati C, Teti G. Role of interleukin 12 in experimental neonatal sepsis caused by group B streptococci. Infect Immun 1997; 65:3731-5.
34. Graveline R, Segura M, Radzioch D, Gottschalk M. TLR2-dependent recognition of Streptococcus suis is modulated by the presence of capsular polysaccharide which modifies macrophage responsiveness. Int Immunol 2007; 19:375-89.
35. Segura M, Vadeboncoeur N, Gottschalk M. CD14-dependent and -independent cytokine and chemokine production by human THP-1 monocytes stimulated by Streptococcus suis capsular type 2. Clin Exp Immunol 2002; 127:243-54.
36. Gottschalk M, Segura M. The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions. Vet Microbiol 2000; 76:259-72.
37. Wangkaew S, Chaiwarith R, Tharavichitkul P, Supparatpinyo K. Streptococcus suis infection: a series of 41 cases from Chiang Mai University Hospital. J Infect 2006; 52:455-60.
38. Halbur P, Thanawongnuwech R, Brown G, et al. Efficacy of antimicrobial treatments and vaccination regimens for control of porcine reproductive and respiratory syndrome virus and Streptococcus suis coinfection of nursery pigs. J Clin Microbiol 2000; 38:1156-60.
39. Donsakul K, Dejthevaporn C, Witoonpanich R. Streptococcus suis infection: clinical features and diagnostic pitfalls. Southeast Asian J Trop Med Public Health 2003; 34:154-8.
40. Schmitt CS, Halbur PG, Roth JA, Kinyon JM, Kasorndorkbua C, Thacker B. Influence of ampicillin, ceftiofur, attenuated live PRRSV vaccine, and reduced dose Streptococcus suis exposure on disease associated with PRRSV and S. suis coinfection. Vet Microbiol 2001; 78:29-37.
41. Leelarasamee A, Nilakul C, Tien-Grim S, Srifuengfung S, Susaengrat W. Streptococcus suis toxic-shock syndrome and meningitis. J Med Assoc Thai 1997; 80:63-8.